Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:2170-2178
doi: 10.1161/hs0901.095650
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Hoffer, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Hoffer, B. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROGEN PEROXIDE
Related Collections
Right arrow Neuroprotectors
Right arrow Apoptosis
Right arrow Acute Cerebral Infarction
Right arrow Growth factors/cytokines

(Stroke. 2001;32:2170.)
© 2001 American Heart Association, Inc.


Original Contributions

Bone Morphogenetic Protein-6 Reduces Ischemia-Induced Brain Damage in Rats

Yun Wang, MD, PhD; Chen-Fu Chang, MD; Marisela Morales, PhD; Jenny Chou, BS; Hui-Ling Chen, MS; Yung-Hsiao Chiang, MD, PhD; Shinn-Zong Lin, MD, PhD; Jean Lud Cadet, MD; Xiaolin Deng, PhD; Jia-Yi Wang, PhD; Su-Yu Chen, MS; Paul L. Kaplan, PhD Barry J. Hoffer, MD, PhD

From the National Institute on Drug Abuse (Y.W., C.-F.C., M.M., J.C., H.-L.C., J.L.C., X.D., B.J.H.), Intramural Research Program, Baltimore, Md; Tri-Service General Hospital (C.-F.C., Y.-H.C., S.-Z.L.), Department of Physiology (J.-Y.W., S.-Y.C.), National Defense Medical Center, Taiwan; and Creative BioMolecules, Inc (P.L.K.), Boston, Mass.

Correspondence to Yun Wang, MD, PhD, National Institute on Drug Abuse, I.R.P., 5500 Nathan Shock Dr, Baltimore, MD 21224. E-mail ywang{at}intra.nida.nih.gov

Background and Purpose— Bone morphogenetic protein-6 (BMP6) and its receptors are expressed in adult and fetal brain. Receptors for BMP6 are upregulated in adult brain after injury, leading to the suggestion that BMP6 is involved in the physiological response to neuronal injury. The purpose of this study was to determine whether there was a neuroprotective effect of BMP6 in vivo and in vitro.

Methods— Lactate dehydrogenase and microtubule-associated protein-2 (MAP-2) activities were used to determine the protective effect of BMP6 against H2O2 in primary cortical cultures. The neuroprotective effects of BMP6 were also studied in chloral hydrate-anesthetized rats. BMP6 or vehicle was injected into right cerebral cortex before transient right middle cerebral artery (MCA) ligation. Animals were killed for triphenyl-tetrazolium chloride staining, caspase-3 immunoreactivity and enzymatic assays, and TUNEL assay. A subgroup of animals were used for locomotor behavioral assays.

Results— Application of H2O2 increased lactate dehydrogenase activity and decreased the density of MAP-2(+) neurons in culture. Both responses were attenuated by BMP6 pretreatment. Complementary in vivo studies showed that pretreatment with BMP6 increased motor performance and generated less cerebral infarction induced by MCA ligation/reperfusion in rats. Pretreatment with BMP6 did not alter cerebral blood flow or physiological parameters. There was decreased ischemia-induced caspase-3 immunoreactivity, caspase-3 enzymatic activity, and density of TUNEL-positive cells in ischemic cortex in BMP6-treated animals.

Conclusions— BMP6 reduces ischemia/reperfusion injury, perhaps by attenuating molecular events underlying apoptosis.


Key Words: apoptosis • bone morphogenetic proteins • cerebral ischemia • neuroprotection • rats




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
W.-C. Shyu, S.-Z. Lin, P.-S. Yen, C.-Y. Su, D.-C. Chen, H.-J. Wang, and H. Li
Stromal Cell-Derived Factor-1{alpha} Promotes Neuroprotection, Angiogenesis, and Mobilization/Homing of Bone Marrow-Derived Cells in Stroke Rats
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 834 - 849.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Lopez-Coviella, M. T. Follettie, T. J. Mellott, V. P. Kovacheva, B. E. Slack, V. Diesl, B. Berse, R. S. Thies, and J. K. Blusztajn
Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons
PNAS, May 10, 2005; 102(19): 6984 - 6989.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. A. Hossain, J. C. Russell, R. O'Brien, and J. Laterra
Neuronal Pentraxin 1: A Novel Mediator of Hypoxic-Ischemic Injury in Neonatal Brain
J. Neurosci., April 28, 2004; 24(17): 4187 - 4196.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Wang, C.-F. Chang, M. Morales, Y.-H. Chiang, B. K. Harvey, T.-P. Su, L.-I Tsao, S. Chen, and C. Thiemermann
Diadenosine Tetraphosphate Protects against Injuries Induced by Ischemia and 6-Hydroxydopamine in Rat Brain
J. Neurosci., August 27, 2003; 23(21): 7958 - 7965.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C.-F. Chang, S.-Z. Lin, Y.-H. Chiang, M. Morales, J. Chou, P. Lein, H.-L. Chen, B. J. Hoffer, and Y. Wang
Intravenous Administration of Bone Morphogenetic Protein-7 After Ischemia Improves Motor Function in Stroke Rats
Stroke, February 1, 2003; 34(2): 558 - 564.
[Abstract] [Full Text] [PDF]